Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenytoin-induced thrombocytopenia

C D Holtzer1, L A Reisner-Keller

  • 1School of Pharmacy, University of California, San Francisco 94110, USA.

The Annals of Pharmacotherapy
|April 1, 1997
PubMed
Summary

Phenytoin can cause severe thrombocytopenia, a dangerous drop in platelets, especially in neurosurgery patients. Prompt recognition and management are crucial to prevent serious complications like bleeding.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genotyping of hepatitis C virus isolates using CLIP sequencing.

Journal of clinical microbiology·2000
Same author

The use of combination antiretroviral therapy in HIV-infected patients.

The Annals of pharmacotherapy·1999
Same author

Simultaneous use of two protease inhibitors in HIV infection.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1999
Same author

Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997.

AIDS (London, England)·1998
Same author

Cross-reactivity in HIV-infected patients switched from trimethoprim-sulfamethoxazole to dapsone.

Pharmacotherapy·1998
Same author

Use of nonnucleoside reverse-transcriptase inhibitors.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1998

Area of Science:

  • Neurology
  • Hematology
  • Pharmacology

Background:

  • Phenytoin is a widely used anticonvulsant medication.
  • It is prescribed for seizure prevention, particularly in neurosurgical patients.
  • Hematologic adverse reactions, including thrombocytopenia, are known but rare side effects of phenytoin.

Observation:

  • A patient developed severe thrombocytopenia 15 days after starting phenytoin for seizure prophylaxis.
  • The thrombocytopenia resolved after phenytoin was discontinued and replaced with phenobarbital.
  • Treatment included platelet transfusion and intravenous immune globulin.

Findings:

  • Phenytoin-induced thrombocytopenia is a rare but serious hematologic reaction.
  • An epoxide metabolite of phenytoin is implicated in platelet destruction, possibly via immune mechanisms.
  • Thrombocytopenia can manifest with confusion, complicating clinical assessment.

Implications:

  • Clinicians must be vigilant for phenytoin-induced thrombocytopenia, especially in neurosurgical populations.
  • Early recognition is vital to avoid severe complications such as cerebral hemorrhage.
  • Understanding this adverse effect is critical for patient safety and effective treatment strategies.

Related Experiment Videos